CHELSEY AZER: Open Payments
NPI 1174112486 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 71 payments from 17 companies in 2025. Trend: 2023 $1,704 · 2024 $1,824 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $306 |
| Madrigal Pharmaceuticals | 6 | $269 |
| ABBVIE INC. | 16 | $204 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| PFIZER INC. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Lilly USA, LLC | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Exact Sciences Corporation | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
Products named: REZDIFFRA, Wegovy, VRAYLAR, REXULTI, NURTEC ODT, Ozempic, JARDIANCE, CAPLYTA.
Industry payments across NY — which companies pay providers there.
